MsrA knockout mouse exhibits abnormal behavior and brain dopamine levels

Free Radical Biology and Medicine

Volumn 45, Issue 2, 2008, Pages 193-200

  Oien, Derek B ^a   Osterhaus, Greg L ^a   Latif, Shaheen A ^a   Pinkston, Jonathan W ^a   Fulks, Jenny ^a   Johnson, Michael ^a   Fowler, Stephen C ^a   Moskovitz, Jackob ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Dopamine; Methionine oxidation; Neurodegenerative diseases; Oxidative stress

Indexed keywords

DOPAMINE; METHIONINE SULFOXIDE REDUCTASE A; TYROSINE 3 MONOOXYGENASE;

ABNORMAL BEHAVIOR; ARTICLE; BRAIN REGION; DEGENERATIVE DISEASE; DOPAMINE BRAIN LEVEL; GAIT; LOCOMOTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGING; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOPAMINE; GAIT; METHIONINE SULFOXIDE REDUCTASES; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; OXIDOREDUCTASES;

MUS;

EID: 44649170935     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.04.003     Document Type: Article

References (39)

1. Tabner B.J., El-Agnaf O.M., German M.J., Fullwood N.J., and Allsop D. Protein aggregation, metals and oxidative stress in neurodegenerative diseases. Biochem. Soc. Trans. 33 (2005) 1082-1086
2. Moskovitz J. Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases. Biochim. Biophys. Acta 1703 (2005) 213-219
3. Moskovitz J., Rahman M.A., Strassman J., Yancey S.O., Kushner S.R., Brot N., and Weissbach H. Escherichia-coli peptide methionine sulfoxide reductase gene - regulation of expression and role in protecting against oxidative damage. J. Bacteriol. 177 (1995) 502-507
4. Moskovitz J., Berlett B.S., Poston J.M., and Stadtman E.R. The yeast peptide methionine sulfoxide reductase functions as an antioxidant in vivo. Proc. Natl. Acad. Sci. U. S. A. (1997) 9585-9589
5. Moskovitz J., Bar-Noy S., Williams W.M., Berlett B.S., and Stadtman E.R. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 12920-12925
6. Gabbita S.P., Aksenov M.Y., Lovell M.A., and Markesbery W.R. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J. Neurochem. 73 (1999) 1660-1666
7. Pal R., Oien D.B., Ersen F.Y., and Moskovitz J. Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse. Exp. Brain Res. 180 (2007) 765-774
8. Dong J., Atwood C.S., Anderson V.E., Siedlak S.L., Smith M.A., Perry G., and Carey P.R. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42 (2003) 2768-2773
9. Choi J., Sullards M.C., Olzmann J.A., Rees H.D., Weintraub S.T., Bostwick D.E., Gearing M., Levey A.I., Chin L.S., and Li L. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 281 (2006) 10816-10824
10. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., and Hanson G.R. New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 681-698
11. McKerchar T.L., Zarcone T.J., and Fowler S.C. Differential acquisition of lever pressing in inbred and outbred mice: comparison of one-lever and two-lever procedures and correlation with differences in locomotor activity. J. Exp. Anal. Behav. 84 (2005) 339-356
12. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Vorontsova E., Wang G., and Zarcone T.J. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J. Neurosci. Methods 107 (2001) 107-124
13. Hampton T.G., Stasko M.R., Kale A., Amende I., and Costa A.C.S. Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome. Physiol. Behav. 82 (2004) 381-389
14. Wooley C.M., Sher R.B., Kale A., Frankel W.N., Cox G.A., and Seburn K.L. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 32 (2005) 43-50
15. Amende I., Kale A., McCue S., Glazier S., Morgan James P., and Hampton Thomas G. Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J. Neuroeng. Rehabil. 2 20 (2005)
16. Bath B.D., Michael D.J., Trafton B.J., Joseph J.D., Runnels P.L., and Wightman R.M. Subsecond adsorption and desorption of dopamine at carbon-fiber microelectrodes. Anal. Chem. 72 (2000) 5994-6002
17. Crocker S.J., Smith P.D., Jackson-Lewis V., Lamba W.R., Hayley S.P., Grimm E., Callaghan S.M., Slack R.S., Melloni E., Przedborski S., Robertson G.S., Anisman H., Merali Z., and Park D.S. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J. Neurosci. 23 (2003) 4081-4091
18. Lee K.W., Lee S.H., Kim H., Song J.S., Yang S.D., Paik S.G., and Han P.L. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. J. Neurosci. Res. 76 (2004) 572-580
19. Salarian A., Russmann H., Vingerhoets F.J.G., Dehollain C., Blanc Y., Burkhard P.R., and Aminian K. Gait assessment in Parkinson's disease: toward an ambulatory system for long-term monitoring. IEEE Trans. Biomed. Eng. 51 (2004) 1434-1443
20. Weller C., Oneill C.J.A., Charlett A., Bowes S.G., Purkiss A., Nicholson P.W., Dobbs R.J., and Dobbs S.M. Defining small differences in efficacy between anti-parkinsonian agents using gait analysis-a comparison of 2 controlled release formulations of levodopa decarboxylase inhibitor. Br. J. Clin. Pharmacol. 35 (1993) 379-385
21. Bartolic A., Pirtosek Z., Rozman J., and Ribaric S. Postural stability of Parkinson's disease patients is improved by decreasing rigidity. Eur. J. Neurol. 12 (2005) 156-159
22. Kale A., Amende N., Meyer G.P., Crabbe J.C., and Hampton T.G. Ethanol's effects on gait dynamics in mice investigated by ventral plane videography. Alcohol. Clin. Exp. Res. 28 (2004) 1839-1848
23. Fernagut P.O., Diguet E., Labattu B., and Tison F. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J. Neurosci. Methods 113 (2002) 123-130
24. Lyon M., and Robbins T. The action of central nervous stimulant drugs: a general theory concerning amphetamine effects. Current developments in psychopharmacology (1975), Spectrum, New York 79-163
25. Kleppe R., Toska K., and Haavik J. Interaction of phosphorylated tyrosine hydroxylase with 14-3-3 proteins: evidence for a phosphoserine 40-dependent association. J. Neurochem. 77 (2001) 1097-1107
26. Gerfen C.R., Herkenham M., and Thibault J. The neostriatal mosaic. 2. Patch-directed and matrix-directed mesostriatal dopaminergic and nondopaminergic systems. J. Neurosci. 7 (1987) 3915-3934
27. Jones S.R., Gainetdinov R.R., Wightman R.M., and Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18 (1998) 1979-1986
28. Wu Q., Reith M.E.A., Wightman R.M., Kawagoe K.T., and Garris P.A. Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J. Neurosci. Methods 112 (2001) 119-133
29. Jones S.R., Joseph J.D., Barak L.S., Caron M.G., and Wightman R.M. Dopamine neuronal transport kinetics and effects of amphetamine. J. Neurochem. 73 (1999) 2406-2414
30. Jones S.R., Garris P.A., Kilts C.D., and Wightman R.M. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus-accumbens of the rat. J. Neurochem. 64 (1995) 2581-2589
31. Kawagoe K.T., Garris P.A., Wiedemann D.J., and Wightman R.M. Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve-terminals in the rat striatum. Neuroscience 51 (1992) 55-64
32. Wightman R.M., Amatore C., Engstrom R.C., Hale P.D., Kristensen E.W., Kuhr W.G., and May L.J. Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25 (1988) 513-523
33. Petropoulos I., Mary J., Perichon M., and Friguet B. Rat peptide methionine sulphoxide reductase: cloning of the cDNA, and down-regulation of gene expression and enzyme activity during aging. Biochem. J. 355 (2001) 819-825
34. Stadtman E.R., Moskovitz J., Berlett B.S., and Levine R.L. Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol. Cell. Biochem. 234-235 (2002) 3-9
35. Yamaguchi H., and Shen J. Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice. Mol. Neurodegen. 2 10 (2007)
36. Chesselet M.F. In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?. Exp. Neurol (2007)
37. Linder J.C., Klemfuss H., and Groves P.M. Acute ultrastructural and behavioral-effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Mptp) in mice. Neurosci. Lett. 82 (1987) 221-226
38. Groves P.M., and Linder J.C. Dendro-dendritic synapses in substantia-nigra - descriptions based on analysis of serial sections. Exp. Brain Res. 49 (1983) 209-217
39. Hattori T., McGeer P.L., and McGeer E.G. Dendro axonic neurotransmission. II. Morphological sites for the synthesis, binding and release of neurotransmitters in dopaminergic dendrites in the substantia nigra and cholinergic dendrites in the neostriatum. Brain Res. 170 (1979) 71-83